PCSK9 and cardiovascular disorder: In further studies, we will screen desirable PCSK9 small molecule inhibitors which can reduce plasma PCSK9 levels in vivo to reveal more PCSK9 functions in cardiovascular diseases beyond LDL-cholesterol plasma level regulation.